|
74 Companies |
|
57 Products |
|
57 Products |
|
42 Mechanisms of Action |
|
2 Trials |
|
680 News |
|
| «12...234567891011121314» |
- ||||| Naftin (naftifine hydrochloride) / Merz Pharma
New P4 trial: Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis (clinicaltrials.gov) - Oct 21, 2012
P4, N=65, Completed, Sponsor: Merz Pharmaceuticals, LLC
- Clinical: Protocol TARC-ABPA (clinicaltrials.gov) - Oct 17, 2012
P=N/A, N=30, Recruiting, Sponsor: Nantes University Hospital
- | Stelara (ustekinumab) / J&J
New P2 trial: A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa (clinicaltrials.gov) - Oct 9, 2012
P2, N=20, Active, not recruiting, Sponsor: University Medical Centre Groningen
- |||| Cubicin (daptomycin) / Merck (MSD)
Trial completion, HEOR: DAPHEOR1006: Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA (clinicaltrials.gov) - Oct 8, 2012
P4, N=250, Completed, Sponsor: Cubist Pharmaceuticals
Recruiting --> Completed
- New P2 trial: Comparative PK Study of Econazole Nitrate Foam and Econazole Nitrate Cream in Subjects With Interdigital Tinea Pedis Aged 12 Years to Less Than 18 Years (clinicaltrials.gov) - Sep 27, 2012
P2, N=42, Completed, Sponsor: Quinnova Pharmaceuticals, Inc.
- | Kenketsu Glovenin-I (normal human immunoglobulin IV) / Takeda
New P3 trial: Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids. (clinicaltrials.gov) - Sep 27, 2012
P3, N=10, Recruiting, Sponsor: Nihon Pharmaceutical Co., Ltd
- ||||||| Trial completion: Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis (clinicaltrials.gov) - Sep 26, 2012
P3, N=336, Completed, Sponsor: AmDerma
Recruiting --> Completed Recruiting --> Completed
- ||||||| Trial completion: Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis (clinicaltrials.gov) - Sep 23, 2012
P3, N=264, Completed, Sponsor: AmDerma
Recruiting --> Completed Recruiting --> Completed
- ||| gentamicin sulfate / Generic mfg.
Trial completion: Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application (clinicaltrials.gov) - Sep 23, 2012
P=N/A, N=108, Completed, Sponsor: U.S. Army Medical Research and Materiel Command
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant (clinicaltrials.gov) - Sep 19, 2012
P2, N=171, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Zeven (dalbavancin) / RaQualia, AbbVie
Trial completion: Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections (clinicaltrials.gov) - Sep 9, 2012
P3, N=573, Completed, Sponsor: Durata Therapeutics, Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- | acyclovir / Generic mfg.
Trial completion: Episodic Acyclovir Therapy for Genital Ulcers (clinicaltrials.gov) - Sep 9, 2012
P2/3, N=613, Completed, Sponsor: Centers for Disease Control and Prevention
Recruiting --> Completed Recruiting --> Completed
- Clinical: Improving Blood Safety and HIV Testing in Brazil (clinicaltrials.gov) - Sep 6, 2012
P=N/A, N=12000, Recruiting, Sponsor: Blood Systems Research Institute
- Kineret (anakinra) / SOBI
Trial initiation date: Anakinra as a Treatment for Hydradenitis Suppurativa (clinicaltrials.gov) - Sep 5, 2012
P2, N=6, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed Initiation date: Jul 2012 --> Oct 2012
- |||| Sivextro (tedizolid) / Merck (MSD), Nabriva Therap
Trial completion, P2 data: A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study (clinicaltrials.gov) - Sep 4, 2012
P2, N=200, Completed, Sponsor: Trius Therapeutics, Inc.
Initiation date: Jul 2012 --> Oct 2012 Active, not recruiting --> Completed
- |||||||||| New P2/3 trial: Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo (clinicaltrials.gov) - Aug 19, 2012
P2/3, N=328, Completed, Sponsor: Galderma
- ||||| HSV vaccine (GEN-003) / Genocea, Shionogi
New P1/2 trial: Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine (clinicaltrials.gov) - Aug 15, 2012
P1/2, N=150, Active, not recruiting, Sponsor: Genocea Biosciences, Inc.
- trimethoprim/sulfamethoxazole / Generic mfg.
Trial completion: Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients (clinicaltrials.gov) - Aug 11, 2012
P=N/A, N=153, Completed, Sponsor: Brigham and Women's Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh (clinicaltrials.gov) - Aug 9, 2012
P=N/A, N=120, Completed, Sponsor: PATH
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Lenocta (sodium stibogluconate) / VioQuest
New P4 trial: Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India (clinicaltrials.gov) - Aug 7, 2012
P4, N=100, Completed, Sponsor: Sarder Patel Medical College
- | Trial completion: Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail (clinicaltrials.gov) - Aug 7, 2012
P2, N=25, Completed, Sponsor: Nitric BioTherapeutics, Inc
Active, not recruiting --> Completed Recruiting --> Completed
- |||| Trial completion, Review, Journal: Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis (clinicaltrials.gov) - Aug 7, 2012
P2, N=168, Completed, Sponsor: Nitric BioTherapeutics, Inc
Recruiting --> Completed Active, not recruiting --> Completed
- | Natroba (spinosad) / Royalty
New P4 trial: Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation (clinicaltrials.gov) - Aug 6, 2012
P4, N=26, Completed, Sponsor: ParaPRO LLC
- |||| Trial completion: A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci (clinicaltrials.gov) - Aug 2, 2012
P2, N=103, Completed, Sponsor: Affinium Pharmaceuticals, Ltd
Active, not recruiting --> Completed Recruiting --> Completed
- | Enrollment change: Replacement of Insecticides to Control Visceral Leishmaniasis (VL) (clinicaltrials.gov) - Jul 30, 2012
P3, N=3600, Recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Recruiting --> Completed N=18000 --> 3600
- ||||| acyclovir / Generic mfg.
New P2 trial: An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode (clinicaltrials.gov) - Jul 29, 2012
P2, N=60, Completed, Sponsor: GlaxoSmithKline
- ||||| Xepi (ozenoxacin) / Maruho, Cipher, Ferrer International
Trial initiation date: Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo (clinicaltrials.gov) - Jul 24, 2012
P3, N=465, Completed, Sponsor: Ferrer Internacional S.A.
N=18000 --> 3600 Initiation date: Oct 2011 --> Mar 2012
- ||||| Zeftera (ceftobiprole) / Basilea
Enrollment change: Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections (clinicaltrials.gov) - Jul 24, 2012
P3, N=828, Completed, Sponsor: Basilea Pharmaceutica
Initiation date: Oct 2011 --> Mar 2012 N=76 --> 828
- phenoxymethylpenicillin / Generic mfg.
Trial completion: PATCH1: RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg (clinicaltrials.gov) - Jul 22, 2012
P4, N=274, Completed, Sponsor: University of Nottingham
N=76 --> 828 Active, not recruiting --> Completed
- Lenocta (sodium stibogluconate) / VioQuest
Trial completion: A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis (clinicaltrials.gov) - Jul 22, 2012
P2, N=45, Completed, Sponsor: Infectious Disease Research Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ciclopirox topical / Generic mfg.
New P4 trial: Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children (clinicaltrials.gov) - Jul 18, 2012
P4, N=21, Terminated, Sponsor: Ferrer Internacional S.A.
- doxycycline / Generic mfg.
Enrollment change: Duration of Antibiotic Treatment of Erythema Migrans (clinicaltrials.gov) - Jul 17, 2012
P=N/A, N=306, Completed, Sponsor: University Medical Centre Ljubljana
Active, not recruiting --> Completed N=405 --> 306
- || New P3 trial: Replacement of Insecticides to Control Visceral Leishmaniasis (VL) (clinicaltrials.gov) - Jul 17, 2012
P3, N=3600, Recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
- |||||||||| CIGB-300 / Center for Genetic Engineering and Biotechnology
New P2/3 trial: Recurrent and Nonrecurrent Condyloma Treatment (clinicaltrials.gov) - Jul 11, 2012
P2/3, N=132, Recruiting, Sponsor: Laboratorio Elea S.A.C.I.F. y A.
- |||||||||| Humira (adalimumab) / Eisai, AbbVie
New P3 trial: PIONEER (OLE): Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa (clinicaltrials.gov) - Jul 8, 2012
P3, N=540, Enrolling by invitation, Sponsor: AbbVie (prior sponsor, Abbott)
- | Cubicin (daptomycin) / Merck (MSD)
Trial termination: Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections (clinicaltrials.gov) - Jun 28, 2012
P3, N=194, Terminated, Sponsor: Novartis Pharmaceuticals
N=405 --> 306 Completed --> Terminated
- | Cubicin (daptomycin) / Merck (MSD)
Enrollment change: Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections (clinicaltrials.gov) - Jun 28, 2012
P3, N=194, Terminated, Sponsor: Novartis Pharmaceuticals
Completed --> Terminated N=280 --> 194
- | voriconazole / Generic mfg.
Trial completion: Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis (clinicaltrials.gov) - Jun 28, 2012
P3, N=212, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
N=280 --> 194 Active, not recruiting --> Completed
- Trial initiation date, Combination therapy: Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis (clinicaltrials.gov) - Jun 18, 2012
P0, N=30, Completed, Sponsor: Tehran University of Medical Sciences
Active, not recruiting --> Completed Initiation date: Dec 2009 --> Mar 2011
- Trial completion, Combination therapy: Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis (clinicaltrials.gov) - Jun 18, 2012
P0, N=30, Completed, Sponsor: Tehran University of Medical Sciences
Initiation date: Dec 2009 --> Mar 2011 Recruiting --> Completed
- Clinical: UARK 2009-99 A Non-interventional Observational Study of Infectious Complications in Cancer Patients (clinicaltrials.gov) - Jun 17, 2012
P=N/A, N=600, Recruiting, Sponsor: University of Arkansas
- acyclovir / Generic mfg.
Trial completion: A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo) (clinicaltrials.gov) - Jun 17, 2012
P1, N=32, Completed, Sponsor: Phillip Brian Smith
Recruiting --> Completed Recruiting --> Completed
- ||| voriconazole / Generic mfg.
New P2/3 trial: Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis (clinicaltrials.gov) - Jun 14, 2012
P2/3, N=50, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
- New P2 trial: Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia (clinicaltrials.gov) - Jun 7, 2012
P2, N=30, Active, not recruiting, Sponsor: Fundaci
- |||||| aztreonam / Generic mfg., vancomycin / Generic mfg., ceftaroline fosamil / Generic mfg.
Enrollment open: Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections (clinicaltrials.gov) - Jun 5, 2012
P3, N=765, Recruiting, Sponsor: AstraZeneca
Recruiting --> Completed Not yet recruiting --> Recruiting
- Tembexa (brincidofovir oral) / SymBio Pharma
New P1/2 trial: A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease) (clinicaltrials.gov) - May 31, 2012
P1/2, N=32, Not yet recruiting, Sponsor: University of Alabama at Birmingham
- | New P4 trial: Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy (clinicaltrials.gov) - May 30, 2012
P4, N=52, Recruiting, Sponsor: Saint Joseph Mercy Health System
- Enrollment open: Clinical Study on Silk Sericin Wound Dressing for Split-thickness Skin Graft Donor Sites Treatment (clinicaltrials.gov) - May 26, 2012
P1/2, N=30, Recruiting, Sponsor: Chulalongkorn University
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Trial termination: Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails (clinicaltrials.gov) - May 20, 2012
P3, N=468, Terminated, Sponsor: Promius Pharma, LLC
Not yet recruiting --> Recruiting Active, not recruiting --> Terminated
- | Trial termination: Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails (clinicaltrials.gov) - May 20, 2012
P3, N=458, Terminated, Sponsor: Promius Pharma, LLC
Active, not recruiting --> Terminated Active, not recruiting --> Terminated